Healthequity Stock Retained Earnings
| HQY Stock | USD 78.54 1.21 1.52% |
HealthEquity fundamentals help investors to digest information that contributes to HealthEquity's financial success or failures. It also enables traders to predict the movement of HealthEquity Stock. The fundamental analysis module provides a way to measure HealthEquity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HealthEquity stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | 205.6 M | 121.8 M | |
| Retained Earnings Total Equity | 253.4 M | 266.1 M |
HealthEquity | Retained Earnings |
HealthEquity Company Retained Earnings Analysis
HealthEquity's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current HealthEquity Retained Earnings | 205.63 M |
Most of HealthEquity's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HealthEquity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HealthEquity Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for HealthEquity is extremely important. It helps to project a fair market value of HealthEquity Stock properly, considering its historical fundamentals such as Retained Earnings. Since HealthEquity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HealthEquity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HealthEquity's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, HealthEquity has a Retained Earnings of 205.63 M. This is 77.92% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The retained earnings for all United States stocks is 97.8% higher than that of the company.
HealthEquity Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HealthEquity's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HealthEquity could also be used in its relative valuation, which is a method of valuing HealthEquity by comparing valuation metrics of similar companies.HealthEquity is currently under evaluation in retained earnings category among related companies.
HealthEquity Fundamentals
| Return On Equity | 0.0284 | ||||
| Return On Asset | 0.0256 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 7.4 B | ||||
| Shares Outstanding | 86.16 M | ||||
| Shares Owned By Insiders | 2.20 % | ||||
| Shares Owned By Institutions | 97.80 % | ||||
| Number Of Shares Shorted | 3.02 M | ||||
| Price To Earning | 525.29 X | ||||
| Price To Book | 3.38 X | ||||
| Price To Sales | 6.88 X | ||||
| Revenue | 999.59 M | ||||
| Gross Profit | 490.09 M | ||||
| EBITDA | 281.21 M | ||||
| Net Income | 55.71 M | ||||
| Cash And Equivalents | 176.89 M | ||||
| Cash Per Share | 2.09 X | ||||
| Total Debt | 933.14 M | ||||
| Debt To Equity | 0.54 % | ||||
| Current Ratio | 2.46 X | ||||
| Book Value Per Share | 23.63 X | ||||
| Cash Flow From Operations | 242.83 M | ||||
| Short Ratio | 4.57 X | ||||
| Earnings Per Share | 0.64 X | ||||
| Price To Earnings To Growth | 2.29 X | ||||
| Target Price | 99.23 | ||||
| Number Of Employees | 3.13 K | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 6.8 B | ||||
| Total Asset | 3.24 B | ||||
| Retained Earnings | 205.63 M | ||||
| Working Capital | 440.35 M | ||||
| Current Asset | 143.05 M | ||||
| Current Liabilities | 12.11 M | ||||
| Net Asset | 3.24 B |
About HealthEquity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HealthEquity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HealthEquity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HealthEquity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HealthEquity Piotroski F Score and HealthEquity Altman Z Score analysis. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.